DMRA

Conviction 100HealthcareScan · Mon, Aug 10, 2026

DMRA$29.56-1.20%

ResistanceSupportVol 14Insider sell

Vol MA14 518.13K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Damora Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.damoratx.com ↗

Price29.56

Change-1.20%

Gap+0.27%

Rel volume3.43×

Avg volume501.86K

Avg $ vol15.11M

SMA 2030.09

SMA 5026.53

SMA 200—

Price vs 50+11.44%

Price vs 200—

MA stack—

50/200 cross—

Supertrendup · 25.33

RSI (14)53

MACD hist-0.22

MACD cross—

Stoch %K / %D27 / 27

ADX (14)20

+DI / −DI18 / 12

RSI divergence—

MACD divergence—

ATR %+7.22%

ADR %7.18%

52w high32.99

52w low18.14

From 52w high-10.40%

Above 52w low+62.95%

New 52w highNo

SqueezeOn · 3d

Bollinger width16.81%

%B0.40

Donchian pos33.46%

Donchian high34.89

Donchian low26.88

AVWAP (52w high)30.08

vs AVWAP high-1.73%

AVWAP (52w low)25.70

vs AVWAP low+15.02%

OBV trendDown

Chaikin MF (20)-0.16

Today vs 20d3.43×

Avg vol (14d)518.13K

Avg vol (20d)501.86K

Avg $ vol (20d)15.11M

Market cap—

RS 3m (vs SPY)+14.03%

RS 6m (vs SPY)—

RS line new highNo

Trend template—

Technical rank68.6

1 week+3.50%

1 month+3.61%

3 months+22.35%

6 months—

1 year—

YTD+15.88%

P/E-8.77

P/B3.60

P/S—

P/FCF-265.97

EPS3.98

Div yield—

ROE-41.02%

ROA-39.19%

Debt/Eq—

Current22.48

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-878.77%

Price target44.43

Target upside48.55%

Analyst ratingBuy

Institutional98.70%

Ent. value1.31B

Revenue—

Net income-27.78M

Gross profit—

Free cash flow-6.92M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out61.55M

Employees7

ListedThu, Oct 29, 2020

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA+

Conviction100 / 100

Pattern quality—

Tech rank68.6 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance33.33

Support23.99

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in DMRA

All disclosures →

No recent disclosed trades by Congress in DMRA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in DMRA · 1 buy · 2 sells

Insider	Side	Shares	Value	Traded	Filed
Winslow Garrett General Counsel · Common Stock · 2026-07-06	Sell	245	$7K	2026-07-06	2026-07-07
Winslow Garrett General Counsel · Common Stock · 2026-07-03	Exercise	680	—	2026-07-03	2026-07-07
Winslow Garrett General Counsel · Restricted Stock Units · 2026-07-03	Exercise	680	—	2026-07-03	2026-07-07

SEC filings

EDGAR filings in DMRA · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.